Prevalence of SARS-CoV-2 Viremia in Presymptomatic Blood Donors in the Delta and Omicron Variant Eras

被引：5

作者：

Saa, Paula ^{[1
]}

Fink, Rebecca, V ^{[2
]}

Dawar, Hina ^{[3
]}

Di Germanio, Clara ^{[3
,4
]}

Montalvo, Leilani ^{[3
]}

Wright, David J. ^{[2
]}

Krysztof, David E. ^{[1
]}

Kleinman, Steven H. ^{[5
]}

Nester, Theresa ^{[6
]}

Kessler, Debra A. ^{[7
]}

Townsend, Rebecca L. ^{[1
]}

Spencer, Bryan R. ^{[1
]}

Kamel, Hany ^{[8
]}

Vannoy, Jackie ^{[8
]}

Busch, Michael P. ^{[3
,4
]}

Stramer, Susan L. ^{[1
]}

Stone, Mars ^{[3
,4
]}

Norris, Philip J. ^{[3
,4
,9
]}

机构：

[1] Amer Red Cross, Sci Affairs, Rockville, MD USA

[2] Westat Corp, Rockville, MD USA

[3] Vitalant Res Inst, San Francisco, CA USA

[4] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA USA

[5] Univ British Columbia, Victoria, BC, Canada

[6] Bloodworks Northwest, Seattle, WA USA

[7] New York Blood Ctr Enterprises, New York, NY USA

[8] Vitalant, Scottsdale, AZ USA

[9] Univ Calif San Francisco, Dept Med, San Francisco, CA USA

来源：

OPEN FORUM INFECTIOUS DISEASES | 2023年 / 10卷 / 05期

关键词：

COVID-19; vaccination; viremia; HEPATITIS-B; RESPONSES; CYTOKINE;

D O I：

10.1093/ofid/ofad253

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Presymptomatic plasma samples from 1596 donors reporting coronavirus disease 2019 infection or symptoms after blood donation were tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA and anti-S and anti-N antibodies. Prior infection and vaccination both protected from developing SARS-CoV-2 RNAemia and from symptomatic infection. RNAemia rates did not differ in the Delta and Omicron variant eras.

引用

页数：5

共 50 条

[21] Omicron: A highly transmissible SARS-CoV-2 variant
Rahimi, Farid
Abadi, Amin Talebi Bezmin
GENE REPORTS, 2022, 27
[22] Audio Interview: The Omicron Variant of SARS-CoV-2
Rubin, Eric J.
Baden, Lindsey R.
Karim, Salim S. Abdool
Morrissey, Stephen
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (23): : E96 - E96
[23] Is the Omicron variant of SARS-CoV-2 coming to an end?
Zhao, Yingjie
Huang, Jianping
Zhang, Li
Lian, Xinbo
Wang, Danfeng
INNOVATION, 2022, 3 (03):
[24] SARS-CoV-2 Omicron variant: Characteristics and prevention
He, Xuemei
Hong, Weiqi
Pan, Xiangyu
Lu, Guangwen
Wei, Xiawei
MEDCOMM, 2021, 2 (04): : 838 - 845
[25] Omicron: A highly transmissible SARS-CoV-2 variant
Rahimi, Farid
Abadi, Amin Talebi Bezmin
GENE REPORTS, 2022, 27
[26] Omicron: A SARS-CoV-2 variant of real concern
Gattinger, Pia
Tulaeva, Inna
Borochova, Kristina
Kratzer, Bernhard
Trapin, Doris
Kropfmuller, Anna
Pickl, Winfried F.
Valenta, Rudolf
ALLERGY, 2022, 77 (05) : 1616 - 1620
[27] Recent insights into SARS-CoV-2 omicron variant
da Silva, Severino Jefferson Ribeiro
Kohl, Alain
Pena, Lindomar
Pardee, Keith
REVIEWS IN MEDICAL VIROLOGY, 2023, 33 (01)
[28] Why is the SARS-CoV-2 Omicron variant milder?
Xia, Bingqing
Wang, Yi
Pan, Xiaoyan
Cheng, Xi
Ji, Hongying
Zuo, Xiaoli
Jiang, Hualiang
Li, Jia
Gao, Zhaobing
INNOVATION, 2022, 3 (04):
[29] Determinants of reinfection with SARS-CoV-2 Omicron variant
Bisharat, N.
Campisi-Pinto, S.
JOURNAL OF INFECTION, 2023, 87 (02) : 163 - 165
[30] Plasma Neutralization of the SARS-CoV-2 Omicron Variant
Schmidt, Fabian
Muecksch, Frauke
Weisblum, Yiska
Da Silva, Justin
Bednarski, Eva
Cho, Alice
Wang, Zijun
Gaebler, Christian
Caskey, Marina
Nussenzweig, Michel C.
Hatziioannou, Theodora
Bieniasz, Paul D.
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (06): : 599 - 601

← 1 2 3 4 5 →